DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic...
Strengthening
Innovative Solutions & Support, Inc. (NASDAQ: ISSC) has acquired the license for Honeywell's military Display...
